Description of Hormonal Contraception's Side Effect on Family Planning Acceptors in the "X" Area Health Center Karanganyar Regency
Abstract
Hormonal contraception use in the Family Planning (KB) program can cause side effects that interfere with health, reduce comfort, and cause the program to stop, in several previous studies, weight gain and menstrual disorders have been reported as the most side effects, but it is suspected that there are still side effects. For others that have not been reported, a complete description of the incidence of side effects is needed to consider the selection of a safe and suitable type of contraception for the acceptor. The purpose of the study was to describe the incidence of side effects and the percentage of events based on the type of hormonal contraception.
This research is an observational descriptive study involving 327 respondents according to the inclusion criteria, using a questionnaire that has been tested for validity and reliability. The study was conducted on family planning acceptors who are in the working area of Puskesmas X Surakarta. Analysis of the results was carried out univariately by the percentage of the number of adverse events based on the type and type of hormonal family planning used.
The results showed that the incidence of side effects in the form of weight gain was 51.8%,, menstrual disorders 38.8%, dizziness 9.1%, nausea 7%, acne 6,1%, and anxiety was 3%. Based on the type of hormonal contraception, the incidence of side effects experienced by acceptors of 3-month injections was 74,3 %, 1-month injections 38,8%, pills 29,9%, and implants was 6,4%.
References
[2] Astuti D, Ilyas H. Faktor-Faktor yang Berhubungan dengan Pemilihan Alat Kontrasepsi Suntik. Jurnal Ilmiah Keperawatan Sai Betik. 2015;(2):11. http://dx.doi.org/10.26630/jkep.v11i2.577
[3] Herowati D, Sugiharto M. Hubungan Antara Kemampuan Reproduksi, Kepemilikan Anak, Tempat Tinggal, Pendidikan Dan Status Bekerja Pada Wanita Sudah Menikah Dengan Pemakaian Kontrasepsi Hormonal Di Indonesia Tahun 2017. hsr. 2019 Aug 6;22(2):91–8. https://doi.org/10.22435/hsr.v22i2.1553
[4] Kurnianta PDM, Soares GIB. Evaluasi Rasionalitas Penggunaan Antidiabetes Oral pada Pasien Diabetes Melitus Tipe 2 Rawat Inap Rumah Sakit Nasional di Dili. Vol 19 No 1 (2022): Jurnal Farmasi Indonesia. 2022;19(1):13. https://doi.org/10.31001/jfi.v19i1.1338
[5] Kristiyanti AAM, Widayati A. Persepsi Masyarakat Tentang Swamedikasi: Studi Kualitatif Dengan Theory of Planned Behavior. jfi. 2022 Apr 30;19(1):181–92. https://doi.org/10.31001/jfi.v19i1.1499
[6] Monayo ER. Faktor – Faktor Yang Mempengaruhi Tingginya Minat Pengguna Kontrasepsi Hormonal Dibandingkan Non Hormonal. JNJ. 2021 Aug 3;3(2):49–58. https://doi.org/10.37311/jnj.v3i2.11339
[7] Aini AN, Mawarni A. Faktor-Faktor yang Berhubungan Dengan Kejadian Drop Out Akseptor KB di Kecamatan Tembalang Kota Semarang. JURNAL KESEHATAN MASYARAKAT. 2016;4:9. https://doi.org/10.14710/jkm.v4i4.13985
[8] Kusumawardani PA, Machfudloh H. Efek Samping KB Suntik Kombinasi (Spotting) dengan Kelangsungan Akseptor KB Suntik Kombinasi. JI-KES. 2021 Aug 31;5(1):33–7. https://doi.org/10.33006/ji-kes.v5i1.227
[9] Multazam AM. Pengaruh Edukasi Penanganan Efek Samping Terhadap Pengetahuan Sikap dan Tingkat Kecemasan Akseptor Keluarga Berencana Hormonal. Jurnal of Muslim Community Health Vol. 2(4):13. https://doi.org/10.52103/jmch.v2i4.697
[10] Sabatini R, Cagiano R, Rabe T. Adverse Effect of Hormonal Contraceptive. . Reproduktionsmed Endokrinol 2011; 8 (Sonderheft 1), 130-156 [Internet]. Available from: https://www.kup.at/kup/pdf/10167.pdf
[11] Tomy Perkasa. Gambaran efek Samping Pada Akseptor Kontrasepsi Hormonal di Puskesmas Colomadu 2 Kabupaten Karanganyar [NASKAH PUBLIKASI]. Universitas Muhammadiyah Surakarta; 2016.
[12] Sujono TA, Milawati A, Hakim AR. Pengaruh Pemakaian Kontrasepsi terhadap Peningkatan Tekanan Darah Wanita di Puskesmas Wonogiri. Jurnal Farmasi Klinik Indonesia. 2013;2:10. http://jurnal.unpad.ac.id/ijcp/article/view/12702
[13] Witono, Suparna Parwodiwiyono. Kepesertaan Keluarga Berencana Pada Masa Awal Pandemi Covid-19 di Daerah Istimewa Yogyakarta. Jurnal Kependudukan, Keluarga, dan Sumber Daya Manusia [Internet]. 1 no 2 Tahun 2020, 77–88. Available from: http://pancanaka.latbangdjogja.web.id/index.php/pancanaka/article/view/47/8 https://doi.org/10.37269/pancanaka.v1i2.47
[14] Noor MS, Yasmina A, Hanggarawati CD. Perbandingan Kejadian Dismenore Pada Akseptor Pil KB Kombinasi Dengan Akseptor Suntik KB 1 Bulan Di Wilayah Kerja Puskesmas Pasayangan. JIKKHC Vol 01/No02/Juni/2017. :4. https://doi.org/10.14710/mkmi.9.1.14-17
[15] Wahyuningsih IR, Putri AK. Studi Komparasi Kenaikan Berat Badan pada Akseptor KB Suntik 1 Bulan dan 3 Bulan di Klinik Griya Husada Karanganyar. Jurnal Placentum, Volume 3, Nomor 1, Februari, 2015. 2015;3:7.
[16] Atania Rachma A, Sri Widatiningsih. Perbedaan Penambahan Berat Badan pada Akseptor Kontrasepsi Suntik 3 Bulan dengan 1 Bulan di Kelurahan Karang Kidul Kecamatan Magelang Selatan Kota Magelang. Jurnal Kebidanan [Internet]. Available from: https://ejournal.poltekkes-smg.ac.id/ojs/index.php/jurkeb https://doi.org/10.31983/jkb.v5i10.1145 https://ejournal.poltekkessmg.ac.id/ojs/index.php/jurkeb/article/view/1145#:~:text=https%3A//doi.org/10.31983/jkb.v5i10.1145
[17] I.Ratna Novalia Sari,Fakultas Kedokteran, Universitas Lampung. Kontrasepsi Hormonal Suntik Depo Medroxyprogesterone Acetate (DMPA) sebagai Salah Satu Penyebab Kenaikan Berat Badan. Medical Journal of Lampung University. Volume 4,Nomor 7 ,Juni 2015,67. https://juke.kedokteran.unila.ac.id/index.php/majority/article/view/145
[18] Dewi LVI, Hakim L. Faktor-Faktor yang Berpengaruh terhadap Adverse Drug Reaction pada Penggunaan Obat Anti Tuberkulosis. 2020;17(02):8. https://doi.org/10.31001/jfi.v17i2.903
[19] Leon Speroff & Philip Darney. 2010. Pedoman Klinis Kontrasepsi, Edisi 2. EGC. Jakarta.
[20] Suratun. Pelayanan Keluarga Berencana dan Pelayanan Kontrasepsi. CV.Trans Info Media. Jakarta. CVTrans Info Media Jakarta. 2013;
[21] Arief,Mansjoer. Kapita Selekta Kedokteran. In: 4th ed. Media Aesculapius Jakarta; 2010.
[22] Rosmiati P. Perbedaan Peningkatan Berat Badan Antara Akseptor KB Suntik 1 bulan (Cyclofem) dengan Akseptor KB Suntik 3 Bulan (Depo Medroksi Progesteron Asetat/DMPA) di Polindes Huko-Huko Kecamatan Pomalaa Kabupaten Kolaka. Kementerian Kesehatan Republik Indonesia Politeknik Kendari Jurusan Kebidanan; 2018. http://repository.poltekkes-kdi.ac.id/679/1/ROSNIAWATI%20P.pdf
[23] Wijayanti Y. Analisis Perbandingan Berat Badan Akseptor Kontrasepsi Suntik 1 Dan 3 Bulan Di Bpm Yetty, S.St Sidoharjo Pringsewu. JIK. 2018 Jul 1;7(2):67–72. 10.35952/jik.v7i2.122
